The Efficacy of Aromatherapy in Alleviating Anxiety among Acute Myocardial Infarction Patients: A Systematic Review and Meta-Analysis.

IF 1.8 4区医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS

Acta Cardiologica Sinica Pub Date : 2025-09-01 DOI:10.6515/ACS.202509_41(5).20250429B

Jia-Ying Hu, Wei-Cheng Lin, Teh-Fu Hsu, Yu-Chi Chen, Chia-Te Chen, Heng-Hsin Tung

{"title":"The Efficacy of Aromatherapy in Alleviating Anxiety among Acute Myocardial Infarction Patients: A Systematic Review and Meta-Analysis.","authors":"Jia-Ying Hu, Wei-Cheng Lin, Teh-Fu Hsu, Yu-Chi Chen, Chia-Te Chen, Heng-Hsin Tung","doi":"10.6515/ACS.202509_41(5).20250429B","DOIUrl":null,"url":null,"abstract":"Background: The primary aim of this study was to explore the effectiveness of aromatherapy in alleviating hospitalization-related anxiety in patients with acute myocardial infarction (AMI).Methods: A search of PubMed, Ovid Medline, Cochrane Library, CINAHL Database, Taiwan Periodical Literature Index System, and Airiti Library was conducted in October 2023. Following the inclusion and exclusion criteria, randomized controlled trials on aromatherapy in patients with AMI aged 18 years or older were identified. The risk of bias in the retrieved trials was assessed using the revised Cochrane Risk-of-Bias Tool for randomized controlled trials.Results: A total of 14 trials were identified. Aromatherapy was found to significantly reduce anxiety (Hedges's g = -2.087, 95% confidence interval [CI] = -2.8341 to -1.341, p < 0.001), although heterogeneity was notably high (I2 = 96.7%). The effects of different aromatherapies on anxiety were inconsistent. Geranium (Hedges's g = -6.970, 95% CI= -10.283 to -3.675, p < 0.001), M. Chamomile (Hedges's g = -3.735, 95% CI= -6.881 to -0.590, p = 0.002), and C. Aurantium (Hedges's g = -3.614, 95% CI= -5.885 to -1.343, p < 0.001) were found to significantly reduce anxiety. Aromatherapy was found to have a significant effect in lowering systolic blood pressure in these patients (Hedges's g = -0.903, 95% CI = -1.689 to -0.117, p = 0.024).Conclusions: Our findings suggest that clinical staff can apply aromatherapy in the care of AMI patients to alleviate anxiety and improve the quality of care.","PeriodicalId":6957,"journal":{"name":"Acta Cardiologica Sinica","volume":"41 5","pages":"583-597"},"PeriodicalIF":1.8000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12464060/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Cardiologica Sinica","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.6515/ACS.202509_41(5).20250429B","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}

引用次数: 0

Abstract

Background: The primary aim of this study was to explore the effectiveness of aromatherapy in alleviating hospitalization-related anxiety in patients with acute myocardial infarction (AMI).

Methods: A search of PubMed, Ovid Medline, Cochrane Library, CINAHL Database, Taiwan Periodical Literature Index System, and Airiti Library was conducted in October 2023. Following the inclusion and exclusion criteria, randomized controlled trials on aromatherapy in patients with AMI aged 18 years or older were identified. The risk of bias in the retrieved trials was assessed using the revised Cochrane Risk-of-Bias Tool for randomized controlled trials.

Results: A total of 14 trials were identified. Aromatherapy was found to significantly reduce anxiety (Hedges's g = -2.087, 95% confidence interval [CI] = -2.8341 to -1.341, p < 0.001), although heterogeneity was notably high (I2 = 96.7%). The effects of different aromatherapies on anxiety were inconsistent. Geranium (Hedges's g = -6.970, 95% CI= -10.283 to -3.675, p < 0.001), M. Chamomile (Hedges's g = -3.735, 95% CI= -6.881 to -0.590, p = 0.002), and C. Aurantium (Hedges's g = -3.614, 95% CI= -5.885 to -1.343, p < 0.001) were found to significantly reduce anxiety. Aromatherapy was found to have a significant effect in lowering systolic blood pressure in these patients (Hedges's g = -0.903, 95% CI = -1.689 to -0.117, p = 0.024).

Conclusions: Our findings suggest that clinical staff can apply aromatherapy in the care of AMI patients to alleviate anxiety and improve the quality of care.

查看原文本刊更多论文

芳香疗法缓解急性心肌梗死患者焦虑的疗效：系统回顾和meta分析。

背景：本研究的主要目的是探讨芳香疗法在缓解急性心肌梗死（AMI）患者住院相关焦虑方面的有效性。方法：于2023年10月检索PubMed、Ovid Medline、Cochrane Library、CINAHL Database、台湾期刊文献索引系统、Airiti Library。根据纳入和排除标准，确定了芳香疗法在18岁及以上AMI患者中的随机对照试验。使用修订后的Cochrane随机对照试验风险偏倚工具对检索到的试验的偏倚风险进行评估。结果：共纳入14项试验。发现芳香疗法显著降低焦虑（Hedges's g = -2.087, 95%可信区间[CI] = -2.8341至-1.341,p < 0.001），尽管异质性非常高（I2 = 96.7%）。不同芳香疗法对焦虑的影响并不一致。天竺葵（Hedges's g = -6.970, 95% CI= -10.283 ~ -3.675, p < 0.001）、洋甘菊（Hedges's g = -3.735, 95% CI= -6.881 ~ -0.590, p = 0.002）、金菊花（Hedges's g = -3.614, 95% CI= -5.885 ~ -1.343, p < 0.001）显著降低焦虑。发现芳香疗法在降低这些患者的收缩压方面有显著效果（Hedges's g = -0.903, 95% CI = -1.689至-0.117,p = 0.024）。结论：临床工作人员可将芳香疗法应用于急性心肌梗死患者的护理中，以减轻患者的焦虑，提高护理质量。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Acta Cardiologica Sinica 医学-心血管系统

CiteScore

2.90

自引率

15.80%

发文量

144

审稿时长

>12 weeks

期刊介绍： Acta Cardiologica Sinica welcomes all the papers in the fields related to cardiovascular medicine including basic research, vascular biology, clinical pharmacology, clinical trial, critical care medicine, coronary artery disease, interventional cardiology, arrythmia and electrophysiology, atherosclerosis, hypertension, cardiomyopathy and heart failure, valvular and structure cardiac disease, pediatric cardiology, cardiovascular surgery, and so on. We received papers from more than 20 countries and areas of the world. Currently, 40% of the papers were submitted to Acta Cardiologica Sinica from Taiwan, 20% from China, and 20% from the other countries and areas in the world. The acceptance rate for publication was around 50% in general.